| Assessment of the expectancy, seriousness and severity of adverse drug reactions reported for chronic obstructive pulmonary disease therapy G Petrova, A Stoimenova, M Dimitrova, M Kamusheva, D Petrova, ... SAGE open medicine 5, 2050312117690404, 2017 | 48 | 2017 |
| Life expectancy and survival analysis of patients with diabetes compared to the non diabetic population in Bulgaria K Tachkov, K Mitov, Y Koleva, Z Mitkova, M Kamusheva, M Dimitrova, ... PloS one 15 (5), e0232815, 2020 | 44 | 2020 |
| Proposal for a regulation on health technology assessment in Europe–opinions of policy makers, payers and academics from the field of HTA P Vella Bonanno, A Bucsics, S Simoens, AP Martin, W Oortwijn, ... Expert review of pharmacoeconomics & outcomes research 19 (3), 251-261, 2019 | 44 | 2019 |
| The European challenges of funding orphan medicinal products M Szegedi, T Zelei, F Arickx, A Bucsics, E Cohn-Zanchetta, J Fürst, ... Orphanet journal of rare diseases 13, 1-8, 2018 | 42 | 2018 |
| The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View. M Kamusheva, D Ignatova, A Golda, A Skowron Integr Pharm Res Pract. 9, 49-63, 2020 | 38 | 2020 |
| Comparative price analysis of biological products for treatment of rheumatoid arthritis M Manova, A Savova, M Vasileva, S Terezova, M Kamusheva, D Grekova, ... Frontiers in pharmacology 9, 393942, 2018 | 38 | 2018 |
| Quality of life and cost study of rheumatoid arthritis therapy with biological medicines VV Boyadzieva, N Stoilov, RM Stoilov, K Tachkov, M Kamusheva, K Mitov, ... Frontiers in pharmacology 9, 794, 2018 | 31 | 2018 |
| Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD) K Tachkov, M Kamusheva, V Pencheva, K Mitov Biotechnology & Biotechnological Equipment 31 (4), 855-861, 2017 | 28 | 2017 |
| Influence of COVID-19 on Health-Related Quality of Life and the Perception of Being Vaccinated to Prevent COVID-19: An Approach for Community Pharmacists from Romania and Bulgaria A Turcu-Stiolica, M Bogdan, MS Subtirelu, AD Meca, AE Tae- rel, I Iaru, ... J. Clin. Med., 864, 2021 | 23 | 2021 |
| Clinical characteristics, treatment patterns, and socio-economic burden of COPD in Bulgaria M Kamusheva, M Dimitrova, JFM van Boven, MJ Postma, T van der Molen, ... Journal of medical economics 20 (5), 503-509, 2017 | 21 | 2017 |
| New Epidemiological, Clinical and Economic Data for Patients With Acromegaly in Bulgaria M Kamusheva, S Vandeva, K Mitov, Y Rusenova, A Elenkova, ... Frontiers in Public Health 8 (147), 2020 | 19 | 2020 |
| A systematic review of collective evidences investigating the effect of diabetes monitoring systems and their application in health care M Kamusheva, K Tachkov, M Dimitrova, Z Mitkova, G García-Sáez, ... Frontiers in endocrinology 12, 636959, 2021 | 17 | 2021 |
| Comparative analysis of legislative requirements about patients' access to biotechnological drugs for rare diseases in Central and Eastern European Countries M Kamusheva, M Manova, AT Savova, GI Petrova, K Mitov, A Harsányi, ... Frontiers in pharmacology 9, 795, 2018 | 17 | 2018 |
| Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles ASMM Maria Kamusheva, Konstantin Tachkov, Guenka Petrova EXPERT OPINION ON ORPHAN DRUGS, 2017 | 15* | 2017 |
| Pharmacist's perspectives on administering a COVID-19 vaccine in community pharmacies in four balkan countries A Turcu-Stiolica, M Kamusheva, M Bogdan, I Tadic, K Harasani, ... Frontiers in public health 9, 766146, 2021 | 14 | 2021 |
| Barriers to use artificial intelligence methodologies in health technology assessment in central and east European countries K Tachkov, A Zemplenyi, M Kamusheva, M Dimitrova, P Siirtola, J Pontén, ... Frontiers in Public Health 10, 921226, 2022 | 13 | 2022 |
| A cross-country comparison of reimbursed orphan medicines in Bulgaria, Greece and Romania M Kamusheva, A Stoimenova, M Doneva, A Zlatareva, G Petrova Biotechnology & Biotechnological Equipment 27 (5), 4186-4192, 2013 | 13 | 2013 |
| Historical overview of regulatory framework development on pricing and reimbursement of medicines in Bulgaria M Vassileva, M Kamusheva, M Manova, A Savova, K Tachkov, G Petrova Expert review of pharmacoeconomics & outcomes research 19 (6), 733-742, 2019 | 10 | 2019 |
| Economic consequences of the vaccination against hepatitis A in the Bulgarian healthcare setting M Dimitrova, G Petrova, K Tachkov, MK Bozhkova, M Kamusheva, K Mitov Biotechnology & Biotechnological Equipment 28 (2), 366-371, 2014 | 10 | 2014 |
| Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers M Kamusheva, B Németh, A Zemplényi, Z Kaló, J Elvidge, M Dimitrova, ... Journal of Comparative Effectiveness Research 11 (12), 905-913, 2022 | 9 | 2022 |
Guenka PetrovaProf. Pharmacoeconomic, Pharmaceutical Legislation, Medical University of Sofia, Faculty of PharmacyVerified email at pharmfac.net
